Human Chorionic Gonadotrophin in an Antagonist Protocol

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

January 31, 2015

Conditions
Infertility
Interventions
DRUG

Low dose HCG

Low dose hCG (200 IU per day) will be given daily when at least six follicles of 12 mm will be observed and E2 (Estradiol) levels are higher than 600 ng/l, until the day of the HCG trigger administration.

DRUG

Placebo

Patients received rFSH injections with Placebo starting on cycle day 3 of the stimulation cycle until the day of hCG trigger administration.

Trial Locations (1)

Unknown

Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT01833858 - Human Chorionic Gonadotrophin in an Antagonist Protocol | Biotech Hunter | Biotech Hunter